However, in large randomized trials assessing AID use, 3453% of participants were still not able to achieve an HbA1c of less than 7% 7,8,9 , primarily because of suboptimal postprandial glucose control 10,11
Weight loss with Semaglutide GLP-1 can present several challenges
Ozempic is not approved by the FDA for weight loss, but it is frequently and legally prescribed by doctors for off-label use
Strive is one of the few providers that directly addresses the bioavailability challenge in their marketing, acknowledging that sublingual delivery differs from injectable and claiming their formulation technology improves upon basic sublingual solutions
Disinhibition, the tendency to overeat in response to emotional or environmental triggers, also improved significantly at all doses above 0.5mg
After 3 days they get used to it and never complain